Xencor, Inc. (XNCR)
12.18
+0.37
(+3.13%)
USD |
NASDAQ |
Feb 25, 13:44
Xencor Research and Development Expense (Quarterly) : 54.37M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 2.151B |
| Merck & Co., Inc. | 3.992B |
| Pfizer Inc. | 3.206B |
| MacroGenics, Inc. | 30.92M |
| Bristol Myers Squibb Co. | 2.561B |